Compare TARA & RAIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
FreightCar America Inc is a manufacturer of railcars and components, serving diverse transportation needs primarily in North America. The company designs and produces a wide range of railcar types, including box cars, hoppers, covered hoppers, gondolas, and flat cars for both intermodal and non-intermodal freight. Its clientele includes shippers, railroads, and financial institutions. The company has two segments: Manufacturing and Parts. The Manufacturing segment encompasses new railcar manufacturing, used railcar sales, leasing, and major rebuilds, while the Parts segment, along with corporate activities, constitutes Corporate and Other. The company's revenue is predominantly derived from its Manufacturing segment, with all revenue generated within the United States.